Table 2.

Overall company spending by year^*

	AbbVie	Amgen	Bristol Myers Squibb	Eli Lilly	Gilead	GSK	Merck	Novartis	Purdue	Roche
2016	6,445,000	5,781,000	3,825,380	1,938,191	2,310,418	2,134,820	9,410,667	4,895,217	3,062,000	8,579,950
2017	13,017,000	10,858,910	7,272,710	5,876,870	5,138,171	2,618,198	9,107,905	10,796,345	2,305,019	7,822,878
2018	13,338,000	10,988,899	5,761,004	6,798,596	4,153,188	3,496,982	8,735,483	12,313,470	1,819,667	9,137,689
2019	12,698,888	9,766,149	6,485,053	9,691,611	3,933,330	3,368,853	6,857,129	11,488,248	1,758,319	11,964,189
2020	14,690,231	9,534,388	6,040,730	7,682,866	3,353,761	4,678,891	4,683,686	8,708,723	1,060,976	6,200,434
Total 2016–2020	60,189,119	46,929,346	28,940,554	31,988,134	18,888,868	16,297,744	38,794,870	48,202,003	10,005,981	43,705,140

^*Amounts in Canadian dollars.